Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.’s Chief Executive Officer, Dr. Amr Morsy, recognized among the top 100 Arabian CEOs of 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., (together with its consolidated subsidiaries, “Rameda”) with ticker name RMDA.CA on EGX, a leading Egyptian pharmaceutical company, announces today that its Chief Executive Officer (CEO), Dr. Amr Morsy, has been named as one of the region’s leading 100 Arabian CEOs at the 2020 G2T Global Awards ceremony, which took place virtually this year.

The G2T Global Awards was established in 2016 to recognize and celebrate excellence in the Arab corporate world. The award winners are selected through a specialized merit system based on 17 specific criteria across through three primary categories: leadership, business, and community service. Dr. Amr Morsy was presented with the award in recognition of his exceptional leadership, sound management, and consistent commitment to Rameda’s stakeholders that transcend beyond the company’s day-to-day operations.

Dr. Amr Morsy, CEO of Rameda, commented, “It is an honour to be recognized for such a prestigious award alongside other esteemed business leaders in Egypt, such as Banque Misr CEO, Mr. Mohamed Eletreby. This year will mark a decade of my tenure with Rameda and together with my colleagues, I look forward to ensuring the company’s continued success while remaining steadfast in our mission to serving our community in the best way that we can”.